RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

168 hedge funds and large institutions have $1.14B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.6M
Puts
$32.3M
Net Calls
Net Calls Change

Top Buyers

1 +$40.5M
2 +$38.3M
3 +$34.1M
4
Deutsche Bank
Deutsche Bank
Germany
+$18M
5
Morgan Stanley
Morgan Stanley
New York
+$16M

Top Sellers

1 -$45.5M
2 -$12.6M
3 -$11.1M
4
GTC
Ghost Tree Capital
New York
-$8.55M
5
Franklin Resources
Franklin Resources
California
-$7.41M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$2.2M
52
$1.99M
53
$1.96M
54
$1.91M
55
$1.79M
56
$1.73M
57
$1.64M
58
$1.51M
59
$1.49M
60
$1.48M
61
$1.31M
62
$1.23M
63
$1.15M
64
$1.15M
65
$1.11M
66
$1.11M
67
$1.07M
68
$1.02M
69
$914K
70
$904K
71
$901K
72
$899K
73
$826K
74
$817K
75
$814K